Reconsider working @Genentech

Quote

anonymous

Guest
I’m going to keep this direct (and it hurts me): if you are in the industry and considering a position at Genentech/Roche, reconsider. It is by far one of the most toxic environments focused less on building science and more on purchasing small companies that are building tech and assets that will not be adopted in the new market. The Medical Affairs organization is chaotic without any true strategy, and the Commercial organization is desperately trying to remain relevant. Thought Leaders are commenting on how bad our reputation has become in treating its employees and advertising crazy internal projects that have nothing to do with advancing what they need: new, true and usable medicines. You’ve got to ask yourself if a company invests more in constant internal transformations (that fail, and lead to other transformations) rather than building a pipeline that will rival their losses in expirations, is it even a company that will exist over time? They reel you in with glamorous perks but once there so many good people get treated so poorly. It’s very sad what it has become. I have tried very hard to recommend solutions and talk through ways we can be fair, equitable, and committed to patients, only to realize the company actually is thriving on its toxicity. Look into it if you need more evidence. Please save yourselves the stress and consider other places.
 






anonymous said:
I’m going to keep this direct (and it hurts me): if you are in the industry and considering a position at Genentech/Roche, reconsider. It is by far one of the most toxic environments focused less on building science and more on purchasing small companies that are building tech and assets that will not be adopted in the new market. The Medical Affairs organization is chaotic without any true strategy, and the Commercial organization is desperately trying to remain relevant. Thought Leaders are commenting on how bad our reputation has become in treating its employees and advertising crazy internal projects that have nothing to do with advancing what they need: new, true and usable medicines. You’ve got to ask yourself if a company invests more in constant internal transformations (that fail, and lead to other transformations) rather than building a pipeline that will rival their losses in expirations, is it even a company that will exist over time? They reel you in with glamorous perks but once there so many good people get treated so poorly. It’s very sad what it has become. I have tried very hard to recommend solutions and talk through ways we can be fair, equitable, and committed to patients, only to realize the company actually is thriving on its toxicity. Look into it if you need more evidence. Please save yourselves the stress and consider other places.
Click to expand...
 






anonymous said:
I’m going to keep this direct (and it hurts me): if you are in the industry and considering a position at Genentech/Roche, reconsider. It is by far one of the most toxic environments focused less on building science and more on purchasing small companies that are building tech and assets that will not be adopted in the new market. The Medical Affairs organization is chaotic without any true strategy, and the Commercial organization is desperately trying to remain relevant. Thought Leaders are commenting on how bad our reputation has become in treating its employees and advertising crazy internal projects that have nothing to do with advancing what they need: new, true and usable medicines. You’ve got to ask yourself if a company invests more in constant internal transformations (that fail, and lead to other transformations) rather than building a pipeline that will rival their losses in expirations, is it even a company that will exist over time? They reel you in with glamorous perks but once there so many good people get treated so poorly. It’s very sad what it has become. I have tried very hard to recommend solutions and talk through ways we can be fair, equitable, and committed to patients, only to realize the company actually is thriving on its toxicity. Look into it if you need more evidence. Please save yourselves the stress and consider other places.
Click to expand...


Having worked there twice, I’d prefer to sell sticky notes at Staples to working in pharma again. Bill A got the ball rolling downhill without a way to stop it and the rest is history. Fortunately most who are no longer there have landed in better opportunities and wouldn’t think of looking at another opportunity at good old Gene.
 












All companies need to change and transform from time to time to adapt the changing environment. Most good companies would retain their core values and identity as they transform. When BA took over, he quickly destroyed our core values and culture by putting profits over people. His inability to relate people to business is apparent. He created a toxic company. We lost our brilliant scientists and R&D leaders. We lost all of our competent commercial leaders. His core belief and emotional disability are so flawed that he should never be a business leader. His incompetency should confine him in the account department where he could not destroy an organization. If you have any options and the right mindset, Genentech should not be in your career path as long as BA is the CEO. Until they clean out the clowns and snakes in the management team, stay away from this dumpster fire.
 












This ship was heading down the wrong strait before BA as well. This has been at least a 4-year wreck waiting to happen with poor decisions leading to poorer “smart sounding” transformative workstreams that got us nothing except being laughed at.
 






anonymous said:
This ship was heading down the wrong strait before BA as well. This has been at least a 4-year wreck waiting to happen with poor decisions leading to poorer “smart sounding” transformative workstreams that got us nothing except being laughed at.
Click to expand...
Totally agree. Old Ian didn't help the situation either.
 






anonymous said:
Totally agree. Old Ian didn't help the situation either.
Click to expand...


Yep. When Art left, Genentech started a downhill race to the bottom. Ian and Troy broke the piggy bank but at least pretended to care about the people. BA practically just showed his massive disdain for the commercial organization on day one. He just accelerated the destruction by showing his sales team his middle finger.
 
























If someone writes a book about how horrible the current management is at Genentech, people would think it is fiction! They are simply the dumbest and most incompetent bunch of clowns. Clueless to a point that would make you laugh if it is not so tragic. Thousands lost their livelihood. Most companies fail unwillingly. This one is committing corporate suicide.
 












anonymous said:
If someone writes a book about how horrible the current management is at Genentech, people would think it is fiction! They are simply the dumbest and most incompetent bunch of clowns. Clueless to a point that would make you laugh if it is not so tragic. Thousands lost their livelihood. Most companies fail unwillingly. This one is committing corporate suicide.
Click to expand...

We have the best mindset though!
 






Genentech is the best company for which to work in the industry, if you enjoy begging for your job every year at the feet of people who should never be trying to lead others.
 
























anonymous said:
Yep. When Art left, Genentech started a downhill race to the bottom. Ian and Troy broke the piggy bank but at least pretended to care about the people. BA practically just showed his massive disdain for the commercial organization on day one. He just accelerated the destruction by showing his sales team his middle finger.
Click to expand...
I’ll take unapproachable Ian over Alexander the cult leader any day. BA is a devil from another level.
 






Top Bottom
Back
Quote